GALECTIN THERAPEUTICS INC — Director's Dealing 2014

Sep 24, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2014-09-23

Reporting Person: OMENN GILBERT S (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25009	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A 12% Convertible Preferred Stock	$		Common Stock (50000)		Direct

Footnotes

F1: The 50,000 shares of Series A Preferred stock are convertible into 4,167 shares of common stock at the option of the holder at any time. There is no expiration date on the conversion into common stock.